Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160055/S057

RxSight Light Adjustable Lens and Light Delivery Device

Rxsight, Inc. · Decision date Nov 5, 2026

MEDTECHLEDGER EXPLANATIONP160055/S057

What did the FDA approve?

FDA lists this as an approval for a supplement to PMA P160055 for RxSight’s Light Adjustable Lens and Light Delivery Device, not a new PMA for the system. The supplied record places it in the ophthalmic device category and identifies the supplement type as a Real-Time Process change tied to design, components, specifications, or material.

The changed item is the Align Assist module: the record says the modification replaces the current template-matching lens identification method with an updated locked machine learning (ML)-based lens identification algorithm. The source does not provide the algorithm’s training data, validation results, performance metrics, or any new clinical indication; it only states the requested change in identification method.

FDA approval order statement

approval for Align Assist module modification proposing replacement of the current template-matching based lens identification methodology with an updated locked machine learning (ML)-based lens identification algorithm
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Ophthalmic
Decision date
Nov 5, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160055/S057
Regulatory pathway
PMA supplement
Applicant
Rxsight, Inc.
Product code
PZK
Decision code
APPR
Decision date
Nov 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Light adjustable lens (LAL) and light delivery device (LDD).

Applicant
Rxsight, Inc.
Product code
PZK
FDA device class
3

For the original device and its historical approval scope, see PMA P160055. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160055 · Original PMA

    LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)

  2. P160055/S057 received

    Application receipt date recorded by FDA.

  3. P160055/S056 · Related supplement

    RxSight Light Adjustable Lens and Light Delivery Device

  4. P160055/S058 · Related supplement

    RxSight Light Adjustable Lens and Light Delivery Device

  5. P160055/S057 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P160055. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160055

Product / regulatory recordCompanyPathwayDecision dateSource
Rxsight, Inc.PMA approvalNov 22, 2017FDA
Rxsight, Inc.PMA supplementSep 3, 2026FDA
Rxsight, Inc.PMA supplementOct 22, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Rxsight, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
100 Columbia, Aliso Viejo, CA, 92656

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records